Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 10.20 -0.15 (-1.45%)
As of 10/9/2025 11:05 AM Eastern

FDBK vs. COG, INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs. Its Competitors

Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends.

In the previous week, Cambridge Cognition's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Cambridge Cognition Neutral
Feedback Neutral

Cambridge Cognition has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

15.8% of Cambridge Cognition shares are held by institutional investors. Comparatively, 36.6% of Feedback shares are held by institutional investors. 3.4% of Cambridge Cognition shares are held by insiders. Comparatively, 8.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-10.07% -68.83% -0.30%
Feedback -279.16%-39.71%-22.99%

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£9.05M1.78-£1.58M-£0.04-913.16
Feedback£885.62K5.05-£10.84M-£0.26-40.00

Summary

Feedback beats Cambridge Cognition on 6 of the 11 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FDBK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£4.47M£369.90M£6.14B£2.61B
Dividend Yield4.56%5.89%5.66%5.28%
P/E Ratio-40.00526.3785.724,428.74
Price / Sales5.05249.51631.45100,208.37
Price / Cash1.1247.1438.3227.90
Price / Book0.185.1513.098.78
Net Income-£10.84M-£15.55M£3.30B£5.89B
7 Day Performance-2.86%-0.11%3.75%0.45%
1 Month Performance-23.31%8.43%10.73%6.03%
1 Year Performance-71.59%14.49%85.28%152.69%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 10.20
-1.4%
N/A-71.4%£4.47M£885.62K-40.0024Gap Down
COG
Cambridge Cognition
N/AGBX 37.45
+1.2%
N/A+1.8%£17.21M£9.05M-985.5380
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/AN/A£9.00M£12.57M-1.7674
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-38.5%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.71
-5.9%
N/A-2.8%£1.14M£114K-14.1231Gap Down
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.627 of 5 stars
GBX 2,370.67
+0.0%
GBX 2,873.67
+21.2%
+20.1%£839.45M£205.66M5,578.04734Gap Down
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
N/AGBX 144.80
-0.8%
GBX 365
+152.1%
-50.9%£51.91M£66.74M689.52478

Related Companies and Tools


This page (LON:FDBK) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners